AQR Arbitrage LLC Has $14.80 Million Stock Holdings in Oaktree Acquisition Corp. III Life Sciences $OACC

Key Points

• AQR Arbitrage LLC has reduced its stake in Oaktree Acquisition Corp. III Life Sciences by 26.7%, now holding 1,450,750 shares worth approximately $14.8 million.
• Other institutional investors have recently acquired new positions in Oaktree Acquisition Corp. III, with total new stakes valued at around $5.6 million in the first quarter alone.
• The stock opened at $10.44 and has maintained a stable trading range, with a one-year low of $9.95 and a high of $10.85.

AQR Arbitrage LLC trimmed its position in shares of Oaktree Acquisition Corp. III Life Sciences (NASDAQ:OACC - Free Report) by 26.7% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,450,750 shares of the company's stock after selling 529,535 shares during the quarter. AQR Arbitrage LLC owned 6.47% of Oaktree Acquisition Corp. III Life Sciences worth $14,798,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in OACC. Toronto Dominion Bank bought a new position in shares of Oaktree Acquisition Corp. III Life Sciences during the fourth quarter worth $14,355,000. Driehaus Capital Management LLC bought a new position in shares of Oaktree Acquisition Corp. III Life Sciences during the first quarter worth $9,180,000. Linden Advisors LP bought a new stake in Oaktree Acquisition Corp. III Life Sciences in the 1st quarter valued at $6,120,000. Ghisallo Capital Management LLC bought a new stake in Oaktree Acquisition Corp. III Life Sciences in the 1st quarter valued at $4,590,000. Finally, Two Sigma Investments LP bought a new stake in Oaktree Acquisition Corp. III Life Sciences in the 4th quarter valued at $4,358,000.

Oaktree Acquisition Corp. III Life Sciences Trading Up 0.1%

OACC traded up $0.01 during trading on Friday, hitting $10.45. The company had a trading volume of 8,158 shares, compared to its average volume of 96,865. Oaktree Acquisition Corp. III Life Sciences has a one year low of $9.95 and a one year high of $10.85. The firm's 50-day moving average price is $10.44 and its 200 day moving average price is $10.34.

Oaktree Acquisition Corp. III Life Sciences Company Profile

Oaktree Acquisition Corp. III Life Sciences is a blank check company, which was created for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded in 1995 and is headquartered in Los Angeles, CA.